AnovaOS Network Powered Patient Registry

NCT05013944 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2024-01-30

No results posted yet for this study

Summary

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Conditions

  • Infectious Disease
  • Neoplasms
  • Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
  • Endocrine, Nutritional and Metabolic Diseases (E00-E89)
  • Mental and Behavioural Disorders
  • Diseases of the Nervous System
  • Diseases of the Eye and Adnexa
  • Diseases of the Ear and Mastoid Process
  • Diseases of the Circulatory System
  • Diseases of the Respiratory System
  • Diseases of the Digestive System
  • Diseases of the Skin and Subcutaneous Tissue
  • Diseases of the Musculoskeletal System and Connective Tissue
  • Diseases of the Genitourinary System
  • Pregnancy, Childbirth and the Puerperium
  • Certain Conditions Originating in the Perinatal Period
  • Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)
  • Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified
  • Injury, Poisoning and Certain Other Consequences of External Causes
  • External Causes of Morbidity and Mortality
  • Factors Influencing Health Status and Contact With Health Services

Sponsors & Collaborators

  • Anova Enterprises, Inc

    lead INDUSTRY

Principal Investigators

  • Martin Walsh · Anova Enterprises, Inc

  • Christopher Beardmore · Anova Enterprises, Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05013944 on ClinicalTrials.gov